On the other hand, a comparable in vivo and in vitro investigation was conducted by Hana and Bawi (2022) to explore the possibility that hesperidin (Hsp) inhibited laryngeal cancer. The gene discussed is HSP90B2P; the disease is laryngeal carcinoma.